<!DOCTYPE html PUBLIC >
<html>
  
  <head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
	<link rel="stylesheet" type="text/css" href="livesite_css\defaults.css">
    <link rel="stylesheet" type="text/css" href="livesite_css\projectroot.css">
    <link rel="stylesheet" type="text/css" href="livesite_css\style.css">
    <title>
      Universal Precautions Implementation Tool
    </title>
    <script src="js\jquery.js">
    </script>
	<script src="js\jquery_ui\jquery-ui.js">
    </script>
    <script src="js\menu.js">
    </script>
    <script src="js\custom-tabs.js">
    </script>
    <script src="js\jquery.cookie.js">
    </script>
    <script src="js\text-resize.js">
    </script>
	<script src="js\jquery.colorbox.js"></script>
	<script src="js\colorbox-script.js"></script>
  </head>
  
  <body>
    <div class="page" id="page">
      <div class="page-width">
        <div id="header">
          <div class="header clearfix">
            <div class="hd-wr clearfix">
              <div class="fl logo">
                <a href="index.html">
                  <img alt="Project Root Logo" height="63" src="img/logo.png" width="332">
                </a>
              </div>
              <div class="fr">
                <div class="search">
                  &nbsp;
                </div>
                <div class="txt-rsg fr">
                  <a class="small " href="javascript:void(0);">
                    A
                  </a>
                  
                  <a class="med active" href="javascript:void(0);">
                    A
                  </a>
                  
                  <a class="large" href="javascript:void(0);">
                    A
                  </a>
                </div>
              </div>
            </div>
          </div>
          <div id="navigation" class="horizontal">
            <div id="block-system-main-menu" class="block block-system block-menu menu-dropdown block-none clearfix">
              <div class="inner tb-terminal">
                <div class="top">
                  <div class="top-inset-1 tb-terminal">
                    <div class="top-inset-2 tb-terminal">
                    </div>
                  </div>
                </div>
                <div class="middle tb-terminal">
                  <div class="content">
                    <ul class="menu pulldown-processed menu-dropdown-js-enabled pulldown">
                      <li class="first leaf level-1 menu-link-2316">
                        <a href="index.html" title="">
                          Home
                        </a>
                      </li>
                      <li class="expanded level-1 menu-link-2971">
                        <a title="" class="menu-dropdown-with-ul">
                          About Rethink Opioids
                          <span class="more-indicator">
                            »
                          </span>
                        </a>
                        
                        <ul class="menu" style="visibility: hidden; display: none;">
                          <li class="first leaf level-2 menu-link-2326">
                            <a href="what-is-project-root.html" title="">
                              What Is Rethink Opioids?
                            </a>
                          </li>
                          <li class="last leaf level-2 menu-link-2331">
                            <a href="steering-committee.html">
                              Meet the Steering Committee
                            </a>
                          </li>
                        </ul>
                      </li>
                      <li class="expanded level-1 menu-link-2976">
                        <a title="" class="menu-dropdown-with-ul">
                          Why Rethink Opioids?
                          <span class="more-indicator">
                            »
                          </span>
                        </a>
                        
                        <ul class="menu" style="visibility: hidden; display: none;">
                          <li class="first collapsed  level-2 menu-link-2336">
                            <a href="why-rethink-opioids.html">
                              Why We Must Rethink Opioids
                            </a>
                          </li>
                          <li class="leaf level-2 menu-link-2341">
                            <a href="prescription-opioid-abuse.html">
                              The Problem of Prescription Opioid Abuse
                            </a>
                          </li>
                          <li class="last leaf level-2 menu-link-2346">
                            <a href="concerns-of-health-care-professionals.html">
                              Concerns of Health Care Professionals and Patients
                            </a>
                          </li>
                        </ul>
                      </li>
                      <li class="expanded level-1 menu-link-2981">
                        <a title="" class="menu-dropdown-with-ul">
                          Practical Approaches
                          <span class="more-indicator">
                            »
                          </span>
                        </a>
                        
                        <ul class="menu" style="display: none; visibility: hidden;">
                          <li class="first leaf level-2 menu-link-2351">
                            <a href="practical-approaches.html">
                              A Framework for Prescribing
                            </a>
                          </li>
                          <li class="collapsed level-2 menu-link-2356">
                            <a href="appropriate-treatment.html">
                              Clinically Appropriate Treatment Selection
                            </a>
                          </li>
                          <li class="collapsed level-2 menu-link-2371">
                            <a href="applying-universal-precautions.html">
                              Applying Universal Precautions When Prescribing
                            </a>
                          </li>
                          <li class="last collapsed level-2 menu-link-2396">
                            <a href="principles-in-practice.html">
                              Universal Precautions in Practice: Case Studies
                            </a>
                          </li>
                        </ul>
                      </li>
                      <li class="last expanded  active-trail level-1 menu-link-2986">
                        <a title="" class="menu-dropdown-with-ul active-trail">
                          Tools and Resources
                          <span class="more-indicator">
                            »
                          </span>
                        </a>
                        
                        <ul class="menu" style="display: none; visibility: hidden;">
                          <li class="first leaf level-2 menu-link-2421">
                            <a href="OverviewofResources.html">
                              Overview of Resources
                            </a>
                          </li>
                          <li class="leaf  level-2 menu-link-2426">
                            <a href="patient-assessment-tools.html">
                              Patient Assessment Tools
                            </a>
                          </li>
                          
                          <li class="leaf active-trail level-2 menu-link-2431">
                            <a class="active-trail active" href="precautions-implementation-tool.html">
                              Universal Precautions Implementation Tool
                            </a>
                          </li>
                          <li class="leaf level-2 menu-link-2436">
                            <a href="guidelines.html">
                              Guidelines and Templates
                            </a>
                          </li>
                          <li class="last leaf level-2 menu-link-2441">
                            <a href="glossary.html">
                              Glossary
                            </a>
                          </li>
                        </ul>
                      </li>
                    </ul>
                  </div>
                </div>
                <div class="bottom">
                  <div class="bottom-inset-1 tb-terminal">
                    <div class="bottom-inset-2 tb-terminal">
                    </div>
                  </div>
                </div>
              </div>
            </div>
          </div>
        </div>
        <div id="content">
          <div class="col-a sidebar left tb-height-balance tb-region tb-scope tb-sidebar tb-left" id="sidebar-a" style="min-height: 499px;">
            <div class="region region-sidebar-a">
              
              <div class="block block-menu block-none clearfix" id="block-menu-menu-tools-and-resources">
                <div class="inner tb-terminal">
                  <div class="top">
                    <div class="top-inset-1 tb-terminal">
                      <div class="top-inset-2 tb-terminal">
                      </div>
                    </div>
                  </div>
                  
                  <div class="middle tb-terminal">
                    
                    
                    
                    
                    <div class="content">
                      <ul class="menu">
                        <li class="first leaf  level-1 menu-link-3001">
                          <a  title="" href="tools-and-resources.html">
                            Overview of Resources
                          </a>
                        </li>
                        <li class="leaf level-1 menu-link-2501">
                          <a title="" href="patient-assessment-tools.html">
                            Patient Assessment Tools
                          </a>
                        </li>
                        
                        <li class="leaf active-trail level-1 menu-link-2506">
                          <a class="active-trail active" title="" href="precautions-implementation-tool.html">
                            Universal Precautions Implementation Tool
                          </a>
                        </li>
                        
                        <li class="leaf level-1 menu-link-2511">
                          <a title="" href="guidelines.html">
                            Guidelines and Templates
                          </a>
                        </li>
                        <li class="last leaf level-1 menu-link-2516">
                          <a title="" href="glossary.html">
                            Glossary
                          </a>
                        </li>
                      </ul>
                      
                    </div>
                    
                  </div>
                  
                  <div class="bottom">
                    <div class="bottom-inset-1 tb-terminal">
                      <div class="bottom-inset-2 tb-terminal">
                      </div>
                    </div>
                  </div>
                </div>
              </div>
              
              <div class="block block-block clearfix" id="block-block-16">
                <div class="inner tb-terminal">
                  <div class="top">
                    <div class="top-inset-1 tb-terminal">
                      <div class="top-inset-2 tb-terminal">
                      </div>
                    </div>
                  </div>
                  
                  <div class="middle tb-terminal">
                    
                    
                    
                    
                    <div class="content">
                      <div class="left-panel flw">
                        <img src="img/left-hand-art4.png">
                      </div>
                      
                    </div>
                    
                  </div>
                  
                  <div class="bottom">
                    <div class="bottom-inset-1 tb-terminal">
                      <div class="bottom-inset-2 tb-terminal">
                      </div>
                    </div>
                  </div>
                </div>
              </div>
            </div>
          </div>
          <div id="main" class="col-c">
            <div class="float-overflow tb-terminal">
              
              <span property="dc:title" content="Why Rethink Opioids?" class="rdf-meta element-hidden">
              </span>
              
              <div class="custom-tabs" id="tabs">
                <ul>
                  <li id="Tab_Overview_universal" class="ui-state-default ui-corner-top ui-tabs-selected ui-state-active">
                    <a href="#tabs-1">
                      Overview
                    </a>
                  </li>
                  <li id="Applying_4_Steps" class="ui-state-default ui-corner-top">
                    <a href="#tabs-2" id="Applying_the_4_Steps">
                      Applying the 4 Steps
                    </a>
                  </li>
                  <li id="Preparing_Dialogue" class="ui-state-default ui-corner-top">
                    <a href="#tabs-3">
                      Preparing for a Dialogue With Patients
                    </a>
                  </li>
                </ul>
                <div id="tabs-1">
                  <div class="acc_wrapper clearfix">
                    <div class="acc_cont clearfix">
                      <div class="thumb_img fl">
                        <a class="universal_prec_img" href="/sites/g/files/g10016691/f/201411/EMB615002-01%20ROOT%20UP%20Implementation%20Tool_v17.pdf">
                          <img src="img/EMB615002-01%20thumbnail.jpg" />
                        </a>
                      </div>
                      <div class="acc_text">
                        <h1>
                          Universal Precautions Implementation Tool
                        </h1>
                        <p>
                          This tool provides an overview of the 4 universal precautions steps for opioid therapy in patients with chronic pain, for your reference. It also presents some discussion points about universal precautions that may help you prepare for a dialogue with patients about the steps. You can 
                          <a class="universal_prec_link" href="/sites/g/files/g10016691/f/201411/EMB615002-01%20ROOT%20UP%20Implementation%20Tool_v17.pdf">
                            download
                          </a>
                          this tool or view the content here on the Web site.
                        </p>
                      </div>
                    </div>
                  </div>
                </div>
                <div id="tabs-2">
                  <div class="acc_wrapper clearfix">
                    <div class="acc_cont clearfix">
                      <div class="thumb_img fl">
                        <a class="inline_pit cboxElement" href="#pop_content" id="Applying_the_4_Steps_Image">
                          <img src="img/EMB615002-01%20UP%20tool%20p1%20thumbnail.jpg" />
                        </a>
                      </div>
                      <h1 class="nospace">
                        Applying the 4 Steps
                      </h1>
                      <p>
                        A 4-step approach to universal precautions for opioid prescribing in patients with chronic pain has been developed as part of the 
                        <a href="what-is-project-root.html">
                          Rethink Opioids
                        </a>
                        initiative.* This graphic presents all of the components of the process at a glance. 
                        <a class="inline cboxElement" href="#pop_content" id="applying_four_steps">
                          Click to expand the 4 steps
                        </a>
                      </p>
                      <div class="topspaceref references">
                        <p>
                          References
                        </p>
                        <ol>
                          <li>
                            <a id="one" name="one">
                            </a>
                            Chou R, Fanciullo GJ, Fine PG, et al; American Pain Society&ndash;American Academy of Pain Medicine Opioids Guidelines Panel. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. 
                            <em>
                              J Pain.
                            </em>
                            2009;10(2):113-130. PMID: 
                            <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19187889">
                              19187889
                            </a>
                          </li>
                          <li>
                            <a id="two" name="two">
                            </a>
                            US Department of Veterans Affairs, US Department of Defense. 
                            <em>
                              VA/DoD Clinical Practice Guideline for Management of Opioid Therapy for Chronic Pain.
                            </em>
                            Version 2.0. Washington, DC: US Dept of Veterans Affairs, US Dept of Defense; 2010. 
                            <a href="http://www.va.gov/PAINMANAGEMENT/docs/CPG_opioidtherapy_summary.pdf">
                              http://www.va.gov/PAINMANAGEMENT/docs/CPG_opioidtherapy_summary.pdf
                            </a>
                            . Accessed May 20, 2014.
                          </li>
                          <li>
                            <a id="three" name="three">
                            </a>
                            Washington State Agency Medical Directors&rsquo; Group (AMDG). 
                            <em>
                              Interagency Guideline on Opioid Dosing for Chronic Non-cancer Pain: An Educational Aid to Improve Care and Safety With Opioid Therapy.
                            </em>
                            2010 Update. Olympia, WA: Washington State Agency Medical Directors Group; 2010. 
                            <a href="http://www.agencymeddirectors.wa.gov/Files/OpioidGdline.pdf">
                              http://www.agencymeddirectors.wa.gov/Files/OpioidGdline.pdf
                            </a>
                            . Accessed May 20, 2014.
                          </li>
                          <li>
                            <a id="four" name="four">
                            </a>
                            Utah Department of Health. 
                            <em>
                              Utah Clinical Guidelines on Prescribing Opioids for Treatment of Pain.
                            </em>
                            Salt Lake City, UT: Utah Dept of Health; 2009. 
                            <a href="http://www.dopl.utah.gov/licensing/forms/OpioidGuidlines.pdf">
                              http://www.dopl.utah.gov/licensing/forms/OpioidGuidlines.pdf
                            </a>
                            . Accessed May 20, 2014.
                          </li>
                          <li>
                            <a id="five" name="five">
                            </a>
                            Webster LR, Fine PG. Approaches to improve pain relief while minimizing opioid abuse liability. 
                            <em>
                              J Pain.
                            </em>
                            2010;11(7):602-611. PMID: 
                            <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20444651">
                              20444651
                            </a>
                          </li>
                          <li>
                            <a id="six" name="six">
                            </a>
                            Gourlay DL, Heit HA, Almahrezi A. Universal precautions in pain medicine: a rational approach to the treatment of chronic pain. 
                            <em>
                              Pain Med.
                            </em>
                            2005;6(2):107-112. PMID: 
                            <a href="http://www.ncbi.nlm.nih.gov/pubmed/15773874">
                              15773874
                            </a>
                          </li>
                          <li>
                            <a id="seven" name="seven">
                            </a>
                            Passik SD. Issues in long-term opioid therapy: unmet needs, risks, and solutions. 
                            <em>
                              Mayo Clin Proc.
                            </em>
                            2009;84(7):593-601. PMID: 
                            <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19567713">
                              19567713
                            </a>
                          </li>
                          <li>
                            <a id="eight" name="eight">
                            </a>
                            Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. 
                            <em>
                              Pain Med.
                            </em>
                            2005;6(6):432-442. PMID: 
                            <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=16336480">
                              16336480
                            </a>
                          </li>
                          <li>
                            <a id="nine" name="nine">
                            </a>
                            Kroenke K, Spitzer RL, Williams JB, Löwe B. An ultra-brief screening scale for anxiety and depression: the PHQ-4. 
                            <em>
                              Psychosomatics.
                            </em>
                            2009;50(6):613-621. PMID: 
                            <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19996233">
                              19996233
                            </a>
                          </li>
                          <li>
                            <a id="ten" name="ten">
                            </a>
                            Löwe B, Wahl I, Rose M, et al. A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire 4 (PHQ-4) in the general population. 
                            <em>
                              J Affect Disord.
                            </em>
                            2010;122(1-2):86-95. PMID: 
                            <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19616305">
                              19616305
                            </a>
                          </li>
                          <li>
                            <a id="eleven" name="eleven">
                            </a>
                            Alliance of States With Prescription Monitoring Programs. Prescription monitoring frequently asked questions (FAQ). 
                            <a href="http://www.pmpalliance.org/pdf/PMP%20FAQ%202012%20-%20FinalForPrint.pdf">
                              http://www.pmpalliance.org/pdf/PMP%20FAQ%202012%20-%20FinalForPrint.pdf
                            </a>
                            Accessed May 20, 2014.
                          </li>
                          <li>
                            <a id="twelve" name="twelve">
                            </a>
                            McDonald DC, Carlson KE. Estimating the prevalence of opioid diversion by &ldquo;doctor shoppers&rdquo; in the United States. 
                            <em>
                              PLoS One.
                            </em>
                            2013;8(7):e69241. PMID:
                            <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=23874923">
                              23874923
                            </a>
                          </li>
                          <li>
                            <a id="thirteen" name="thirteen">
                            </a>
                            Peppin JF, Passik SD, Couto JE, et al. Recommendations for urine drug monitoring as a component of opioid therapy in the treatment of chronic pain. 
                            <em>
                              Pain Med.
                            </em>
                            2012;13(7):886-896. PMID: 
                            <a href="http:/www.ncbi.nlm.nih.gov/pubmed/?term=22694154">
                              22694154
                            </a>
                          </li>
                          <li>
                            <a id="fourteen" name="fourteen">
                            </a>
                            US Food and Drug Administration. ER/LA Opioid Analgesic Class Labeling Changes and Postmarket Requirements. Letter to ER/LA opioid application holders. 
                            <a href="http://www.fda.gov/downloads/Drugs/DrugSafety/InformationbyDrugClass/UCM367697.pdf">
                              http://www.fda.gov/downloads/Drugs/DrugSafety/InformationbyDrugClass/UCM367697.pdf
                            </a>
                            Accessed May 20, 2014.
                          </li>
                          <li>
                            <a id="fifteen" name="fifteen">
                            </a>
                            Cleeland CS. 
                            <em>
                              The Brief Pain Inventory: User Guide.
                            </em>
                            2009. 
                            <a href="http://www.mdanderson.org/education-and-research/departments-programs-and-labs/departments-and-divisions/symptom-research/symptom-assessment-tools/BPI_UserGuide.pdf">
                              http://www.mdanderson.org/education-and-research/departments-programs-and-labs/departments-and-divisions/symptom-research/symptom-assessment-tools/BPI_UserGuide.pdf
                            </a>
                            Accessed May 20, 2014.
                          </li>
                          <li>
                            <a id="sixteen" name="sixteen">
                            </a>
                            Breivik H, Borchgrevink PC, Allen SM, et al. Assessment of pain. 
                            <em>
                              Br J Anaesth.
                            </em>
                            2008;101(1):17-24. PMID: 
                            <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=18487245">
                              18487245
                            </a>
                          </li>
                          <li>
                            <a id="seventeen" name="seventeen">
                            </a>
                            Chou R, Fanciullo GJ, Fine PG, Miaskowski C, Passik SD, Portenoy RK. Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. 
                            <em>
                              J Pain.
                            </em>
                            2009;10(2):131-146. PMID: 
                            <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19187890">
                              19187890
                            </a>
                          </li>
                          <li>
                            <a id="eighteen" name="eighteen">
                            </a>
                            Butler SF, Budman SH, Fernandez KC, et al. Development and validation of the Current Opioid Misuse Measure. 
                            <em>
                              Pain.
                            </em>
                            2007;130(1-2):144-156. PMID: 
                            <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=17493754">
                              17493754
                            </a>
                          </li>
                          <li>
                            <a id="nineteen" name="nineteen">
                            </a>
                            US Food and Drug Administration. 
                            <em>
                              Guidance for Industry: Abuse-Deterrent Opioids&mdash;Evaluation and Labeling
                            </em>
                            [draft guidance]. Silver Spring, MD: FDA; 2013.
                          </li>
                          <li>
                            <a id="twenty" name="twenty">
                            </a>
                            Stanos S. Continuing evolution of opioid use in primary care practice: implications of emerging technologies. 
                            <em>
                              Curr Med Res Opin.
                            </em>
                            2012;28(9):1505-1516. PMID: 
                            <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=22937723">
                              22937723
                            </a>
                          </li>
                        </ol>
                      </div>
                    </div>
                  </div>
                  <div class="ltbox-cont clearfix">
                    <div class="popup_box" id="pop_content">
                      <img src="img/EMB615002-01%20UP%20tool%20p2%20thumbnail.jpg" />
                    </div>
                  </div>
                </div>
                <div id="tabs-3">
                  <div class="acc_wrapper clearfix">
                    <div class="acc_cont clearfix">
                      <h1>
                        Preparing for a Dialogue With Patients
                      </h1>
                      <div class="acc_text">
                        <p>
                          Patients may question the necessity of universal precautions or ask for more details about the 4-step process. The following suggestions may help you prepare for discussion with your patients.
                        </p>
                        <h3 class="uni-heading">
                          Importance of Universal Precautions
                        </h3>
                        <div class="univer-precaution">
                          <ul>
                            <li>
                              Explain that 
                              <a href="applying-universal-precautions.html " id="universal_precautions_UPIT">
                                universal precautions
                              </a>
                              are intended to help protect patients, their families, and society from the known risks of opioid medications.
                              <sup>
                                <a href="#twp_one">
                                  1
                                </a>
                                ,
                                <a href="#twp_two">
                                  2
                                </a>
                              </sup>
                              (Refer to the Patient Counseling Information and Medication Guide in product labeling for guidance on discussing risks and benefits of specific agents.)
                            </li>
                            <li>
                              Emphasize that you apply these precautions to every patient being considered for opioid therapy for chronic pain.
                            </li>
                            <li>
                              Briefly review the 4 steps in the process: 
                              <a href="assess-risk.html" id="Assess_Risk_UPIT">
                                Assess Risk
                              </a>
                              , 
                              <a href="select-agent.html" id="Select_Agent_UPIT">
                                Select Agent
                              </a>
                              , 
                              <a href="dialogue-with-patient.html" id="Dialogue_With_Patient_UPIT">
                                Dialogue With Patient
                              </a>
                              , 
                              <a href="monitor-treatment.html" id="Monitor_Treatment_UPIT">
                                Monitor Treatment
                              </a>
                              .
                            </li>
                          </ul>
                        </div>
                        <h3 class="uni-heading">
                          Rationale for Risk Assessment Tools
                        </h3>
                        <div class="univer-precaution">
                          <ul>
                            <li>
                              <strong>
                                Risk questionnaires:
                              </strong>
                              Explain that these tools (eg, 
                              <a href="assess-risk#1" id="Opioid_Risk_Tool_UPIT">
                                Opioid Risk Tool
                              </a>
                              ) are intended to help you make appropriate treatment decisions and are an important part of the universal precautions process.
                              <sup>
                                <a href="#twp_three">
                                  3
                                </a>
                              </sup>
                            </li>
                            <li>
                              <strong>
                                <a href="assess-risk#2" id="Psychological_assessment_UPIT">
                                  Psychological assessment
                                </a>
                                :
                              </strong>
                              Point out that this is an important step because a personal or family history of psychological illness has been linked to increased risk with opioids.
                              <sup>
                                <a href="#twp_four">
                                  4
                                </a>
                              </sup>
                            </li>
                            <li>
                              <strong>
                                <a href="assess-risk#3" id="Prescription_monitoring_program_UPIT">
                                  Prescription monitoring program
                                </a>
                                :
                              </strong>
                              If your state has a program in place, explain that you check prescription records to document the patient&rsquo;s prescriptions for controlled substances. Point out (if it is true in your state) that you are required to check these records before prescribing a controlled substance such as an opioid.
                              <sup>
                                <a href="#twp_five">
                                  5
                                </a>
                                ,
                                <a href="twp_six">
                                  6
                                </a>
                              </sup>
                            </li>
                            <li>
                              <strong>
                                <a href="assess-risk#4" id="Urine_drug_testing_UPIT">
                                  Urine drug testing
                                </a>
                                :
                              </strong>
                              Explain that these tests are an important part of your risk assessment for all patients being considered for opioid therapy for chronic pain.
                              <sup>
                                <a href="#twp_one">
                                  1
                                </a>
                                ,
                                <a href="#twp_three">
                                  3
                                </a>
                                ,
                                <a href="#twp_seven">
                                  7
                                </a>
                              </sup>
                              Point out that urine tests may be repeated randomly if opioid therapy is continued long-term.
                              <sup>
                                <a href="#twp_three">
                                  3
                                </a>
                              </sup>
                            </li>
                          </ul>
                        </div>
                        <h3 class="uni-heading">
                          Selection of an Abuse-deterrent Opioid
                        </h3>
                        <div class="univer-precaution">
                          <ul>
                            <li>
                              If you are prescribing an 
                              <a href="select-agent#2" id="ADF_UPIT">
                                abuse-deterrent opioid
                              </a>
                              , explain that these products are designed with technology intended to make manipulation of the medication more difficult or to make abuse of the manipulated medication less attractive or rewarding.
                              <sup>
                                <a href="#twp_eight">
                                  8
                                </a>
                              </sup>
                              Provide an example appropriate to the abuse-deterrent opioid you are prescribing.
                            </li>
                            <li>
                              Explain that you prescribe abuse-deterrent opioids, when they are appropriate and available, to every patient who takes opioids long-term, as part of universal precautions.
                              <sup>
                                <a href="#twp_one">
                                  1
                                </a>
                              </sup>
                            </li>
                            <li>
                              Point out that abuse-deterrent opioids do not stop people from taking too many pills, which is the most common form of opioid abuse.
                              <sup>
                                <a href="#twp_eight">
                                  8
                                </a>
                              </sup>
                            </li>
                          </ul>
                        </div>
                        <h3 class="uni-heading">
                          Purpose of a Written Treatment Agreement
                        </h3>
                        <div class="univer-precaution">
                          <ul>
                            <li>
                              Explain that a written 
                              <a href="dialogue-with-patient#2" id="treatment_agreement_UPIT">
                                treatment agreement
                              </a>
                              is intended to help prevent misunderstandings about how the opioid medication should be used.
                              <sup>
                                <a href="#twp_three">
                                  3
                                </a>
                              </sup>
                            </li>
                            <li>
                              Point out that the agreement serves to summarize and formalize your discussion about the proper use of the medication.
                              <sup>
                                <a href="#twp_seven">
                                  7
                                </a>
                              </sup>
                            </li>
                          </ul>
                        </div>
                      </div>
                      <div class="references">
                        <p>
                          References
                        </p>
                        <ol>
                          <li>
                            <a id="twp_one" name="one">
                            </a>
                            Webster LR, Fine PG. Approaches to improve pain relief while minimizing opioid abuse liability. 
                            <em>
                              J Pain
                            </em>
                            . 2010;11(7):602-611. PMID: 
                            <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20444651" target="_blank">
                              20444651
                            </a>
                          </li>
                          <li>
                            <a id="twp_two" name="two">
                            </a>
                            Passik SD. Issues in long-term opioid therapy: unmet needs, risks, and solutions. 
                            <em>
                              Mayo Clin Proc
                            </em>
                            . 2009;84(7):593-601. PMID:
                            <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19567713" target="_blank">
                              19567713
                            </a>
                          </li>
                          <li>
                            <a id="twp_three" name="three">
                            </a>
                            Washington State Agency Medical Directors&rsquo; Group (AMDG). 
                            <em>
                              Interagency Guideline on Opioid Dosing for Chronic Non-cancer Pain: An Educational Aid to Improve Care and Safety With Opioid Therapy
                            </em>
                            . 2010 Update. Olympia, WA: Washington State Agency Medical Directors Group; 2010. http://www.agencymeddirectors.wa.gov/Files/OpioidGdline.pdf. Accessed May 20, 2014.
                          </li>
                          <li>
                            <a id="twp_four" name="four">
                            </a>
                            Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. 
                            <em>
                              Pain Med
                            </em>
                            . 2005;6(6):432-442. PMID: 
                            <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=16336480" target="_blank">
                              16336480
                            </a>
                          </li>
                          <li>
                            <a id="twp_five" name="five">
                            </a>
                            Federation of State Medical Boards. Prescription drug monitoring programs: state-by-state overview. Updated October 2013. http://www.fsmb.org/pdf/GRPOL_pmp_overview_by_state.pdf. Accessed May 20, 2014.
                          </li>
                          <li>
                            <a id="twp_six" name="six">
                            </a>
                            US Dept of Justice, Drug Enforcement Administration Website. State Prescription Drug Monitoring Programs: Questions and Answers. Updated October 11, 2011. http://www.deadiversion.usdoj.gov/faq/rx_monitor.htm. Accessed October 8, 2014.
                          </li>
                          <li>
                            <a id="twp_seven" name="seven">
                            </a>
                            US Department of Veterans Affairs, US Department of Defense. 
                            <em>
                              VA/DoD Clinical Practice Guideline for Management of Opioid Therapy for Chronic Pain
                            </em>
                            . Version 2.0. Washington, DC: US Dept of Veterans Affairs, US Dept of Defense; 2010. http://www.va.gov/PAINMANAGEMENT/docs/CPG_opioidtherapy_summary.pdf. Accessed May 20, 2014.
                          </li>
                          <li>
                            <a id="twp_eight" name="eight">
                            </a>
                            US Food and Drug Administration. 
                            <em>
                              Guidance for Industry: Abuse-Deterrent Opioids&mdash;Evaluation and Labeling
                            </em>
                            [draft guidance]. Silver Spring, MD: FDA; 2013.
                          </li>
                        </ol>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
              <div class="custom-tabs">
                &nbsp;
              </div>
            </div
              
            </div>
          </div>
        </div>
          <div id="footer">
      <div class="ft clearfix">
        <div class="ft-wr clearfix">
          <span>
            Any product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.
          </span>
        </div>
        
        <div class="ft-wr clearfix">
          <div class="pf-logo fl">
            <img alt="Pfizer Logo" height="35" src="img/pfizer-logo.png" width="56">
          </div>
          
          <p class="fl">
            Copyright © 2014 Pfizer Inc. All rights reserved. EMB695705-01
          </p>
        </div>
      </div>
    </div>
      </div>
      
    </div>
  
  </div>
</div>
</body>

</html>
